Corvus Pharmaceuticals Stock Price Down 8.6 percent Time to Sell?
| CRVS Stock | USD 8.24 0.16 1.90% |
Slightly above 62% of Corvus Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Corvus Pharmaceuticals suggests that many traders are alarmed. Corvus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Corvus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Corvus |
Corvus Pharmaceuticals, Inc. s stock price was down 8.6 percent on Tuesday . The stock traded as low as 8.73 and last traded at 8.74. Approximately 493,465 shares traded hands during trading, an increase of 40 percent from the average daily volume of 353,164 shares. The stock had previously closed at 9.56. Analyst
Read at thelincolnianonline.com
 |